The new Clinical Trials Information System (CTIS), which centralizes processes with the aim of speeding up these studies, is now operational Source: www.actasanitaria.com With the entry […]

A report on the research pipeline of global pharmaceutical companies highlights the importance of this ‘first-in-class’ share for patients with unmet medical needs. It captures notable […]

More than 50% of the trials with new treatments are currently concentrated in Madrid and Barcelona Spain, a benchmark in clinical research, should also bet on […]

Source: www.actasanitaria.com The Spanish Agency for Medicines and Health Products (AEMPS) has published the ‘Memorandum of collaboration between the ethics committees of research with medicines (CEIm) […]

Source: www.immedicohospitalario.es The foundation works to eradicate cancer worldwide through clinical research, teaching and information to the population This Wednesday, November 3, MD Anderson Cancer Center […]

Source: www.actasanitaria.com Farmaindustria, the employers’ association of the innovative pharmaceutical industry in Spain, has highlighted the role of this sector in Europe “as one of the […]

Biomedical innovation cannot be considered an expense, but rather an investment that redounds in the medium and long term in health systems and in society as […]

Via: www.consalud.es The pharmaceutical industry investment in R&D has increased during 2020 despite the coronavirus pandemic, but the productivity of clinical trials remains below average. This […]

Via: www.immedicohospitalario.es Clinical trials mobilize financial resources, allow health professionals to add research experience to their care activity and provide patients with early access to new […]

Researchers at pharmaceutical companies are working to develop innovative antibacterial treatments, such as bacteriophages, live therapeutics, and monoclonal antibodies. The development period for new antimicrobials can […]

In just two decades, the European Union has gone from leading global biomedical R&D to being the origin of only 23% of new drugs, while 47% […]

The pandemic has prompted the digitization of some clinical trial processes, but questions remain to be resolved in the globalized management of health data Farmaindustria defends […]